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Dosage adjustment in medical patients with renal 
impairment at Groote Schuur Hospital
Eric Decloedt, Rory Leisegang, Marc Blockman, Karen Cohen
Failure to adjust dosing of renally excreted drugs in patients 
with renal impairment may lead to adverse effects, including 
nephrotoxicity. The incidence of in-hospital acute kidney injury 
attributed to drug nephrotoxicity is estimated at 19%.1 Drug-
induced nephrotoxicity and adverse effects can be reduced by 
adjusting the dosing of renally excreted drugs according to the 
patient’s estimated glomerular filtration rate (eGFR), but this is 
often neglected by prescribers. In renally impaired patients,  
29 - 74% of drug prescriptions requiring dose adjustment are 
not appropriately adjusted.2-7
We conducted a retrospective cross-sectional study to 
determine the prevalence of incorrect dosing of renally 
eliminated drugs among general medical patients with renal 
impairment at Groote Schuur Hospital (GSH), Cape Town. We 
aimed to determine what proportion of drugs prescribed to 
patients with renal impairment (defined as an eGFR of ≤50 ml 
per minute per 1.73 m2) in the general medical wards required 
dose adjustment; and to determine whether drug doses were 
appropriately adjusted in these patients, using Drug Prescribing 
in Renal Failure as our reference for dose adjustments.8
Methods
We reviewed folders of all patients admitted to the general 
medical wards of GSH between 1 January and 31 March 2008. 
The serum creatinine concentration, measured on the day of 
admission to the medical ward, was extracted. If this had not 
been measured at that time, the creatinine result with which 
the patient was referred to the medical ward from casualty 
or a referring hospital was used. eGFR was calculated using 
the abbreviated Modification of Diet in Renal Disease study 
equation (MDRD): eGFR=186 × (Scr/88.4)-1.154 × (age)-0.203 
× (0.742 if female) × (1.212 if African-American).9-11 This 
formula requires age, sex, creatinine and ethnicity as inputs. 
As recommended by the South African Renal Society, the 
adjustment factor recommended for African-American patients 
was included in the equation for black patients, and omitted 
in those of other ethnicity.11 We categorised patient ethnicity 
as black if the patient was recorded as Xhosa-speaking in 
the admission record. We included all patients with renal 
impairment, defined as an eGFR ≤50 ml per minute per 1.73 
m2, who received treatment in the medical ward for at least 1 
day after a serum creatinine test was performed. Drug details 
were extracted from prescription charts on the day that the 
clinical notes indicated that the renal function was reviewed. 
When no mention of the renal function was made in the clinical 
notes, we extracted prescribed drugs from prescription charts 
at least 1 day after the serum creatinine was measured. This 
step ensured that prescribers had had a 1-day period after renal 
function was assessed in which to adjust drug doses. We used 
Drug Prescribing in Renal Failure to identify drugs requiring 
dose adjustment, and to determine if the appropriate dose 
adjustment for the patient’s eGFR had occurred.8
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Background. Many drugs are eliminated by the kidneys and 
therefore may require dose adjustment in patients with renal 
impairment. The need for dose adjustment is frequently 
neglected by prescribers.
Methods. We reviewed folders of patients admitted to the 
Groote Schuur Hospital general medical wards between 
January and March 2008. Patients with renal impairment, 
defined as an estimated glomerular filtration rate (eGFR) 
≤50 ml per minute per 1.73 m2, were identified. In-patient 
prescriptions were captured if they were written after clinical 
notes indicated impaired renal function, or ≥1 day after 
renal function tests were performed. We determined what 
proportion of these prescriptions required dose adjustment 
and whether drug doses were appropriately adjusted.
Results. We found renal impairment in 32% (97/301) of 
medical admissions. There were 615 prescription entries for 
the 97 patients with renal impairment. Dose adjustment was 
required in 19% (117/615) of prescription entries, and only 
32% (37/117) of these prescription entries were correctly 
dose adjusted. Of 97 patients, 69 received one or more drugs 
that required dose adjustment (median 1, range 1 - 5). All 
drug doses were correctly adjusted in 12% (8/69) of patients. 
Importantly, in the majority of patients (59% (41/69)) no doses 
had been correctly adjusted.
Conclusion. Consistent with international studies, drug dose 
adjustment in patients with renal impairment in a South 
African hospital was frequently neglected. Strategies to alert 
clinicians of the need for dose adjustment in renal impairment 
should be considered, including automated eGFR reporting 
and computerised aids to guide drug dosing, that account for 
renal impairment.
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Data management and analysis
Data from the patient folders were entered into an AccessTM 
database. Statistical analyses were performed using Stata 10.0 
(Stata Corporation, College Station, Texas, USA). Numerical 
variables were summarised using median and range or 
interquartile range (IQR). Associations between categorical 
variables were explored using the chi-square test of association.
Ethical approval
Ethical approval was obtained from the Human Research 
Ethics Committee of the Faculty of Health Sciences, University 
of Cape Town.
Results
Between January and March 2008, 433 patients were admitted 
to the general medical wards. We located and assessed 317 
folders, of which 303 had complete notes. The eGFR was 
>50 ml per min per 1.73 m2 in 204 patients, and 2 patients 
with renal impairment were transferred from the ward to the 
intensive care unit within 24 hours of admission. Therefore, 97 
patients fulfilled our inclusion criteria and were included in the 
final analysis: 32% (97/301) of medical admissions.
The median age of patients with renal impairment was 
46 years; 52% were female; the median number of drugs 
prescribed per patient was 6 (range 1 - 15) and 55% (53/97) 
had ≥5 drugs prescribed. The median eGFR was 19 ml per min 
per 1.73m2 (IQR 9 - 33), with a median creatinine of 448 µmol/l 
(IQR 314 - 950) (Table I).
There were 615 prescription entries for the 97 patients with 
renal impairment. In total, 110 different drugs were prescribed, 
and some prescribed on multiple occasions. Dose adjustment 
was required in 19% (117/615) of prescription entries. Of the 
117 prescription entries, only 37 were correctly dose adjusted 
(32%).
Co-amoxiclavulanic acid was the most frequently prescribed 
drug that required dose adjustment, which was done in 21% 
(5/24) of cases; followed by atenolol and gliclazide, adjusted 
in 26% (5/19) of cases and 25% (2/8) of cases respectively. Of 
the most frequently prescribed drugs, ethambutol was the only 
drug correctly dose adjusted in all cases (6/6). Ciprofloxacin 
and digoxin both required dose adjustment in 5 cases, and 
remained unadjusted in all cases.
Of the 97 patients, 71% (69/97) received ≥1 drug that 
required dose adjustment (median 1; range 1 - 5). Only 12% 
(8/69) of patients had all of their drugs correctly adjusted; 29% 
(20/69) of patients had some drugs correctly adjusted; 59% 
(41/69) of patients had no drugs correctly adjusted.
On univariate analysis, we found no association between 
dose adjustment and sex, age, extent of renal impairment or the 
number of prescription items. Nine patients were documented 
to have received dialysis before or on the day when the 
prescription was reviewed for dose adjustment. No patients 
receiving dialysis had all of their prescription items correctly 
adjusted, and 89% (8/9) had one or more inappropriately 
dosed prescription entries.
Discussion
Renal impairment occurred in 32% (97/301) of patients 
admitted for ≥24 hours in the general medical wards at GSH. 
Dose adjustment was required in 19% of prescription entries 
in patients with renal impairment, and only 32% of those 
prescriptions were correctly dose adjusted. One or more drugs 
requiring dose adjustment were prescribed to 71% (69/97) of 
patients with renal impairment. In most patients prescribed 
drugs requiring dose adjustment (59%), none was correctly 
adjusted. Worryingly, 8/9 dialysed patients had at least one 
prescription item incorrectly dosed.
To our knowledge, this is the first study in general medical 
patients with renal impairment of the frequency of dose 
adjustment of renally excreted drugs in South Africa. Our 
findings are in keeping with international studies, which found 
inappropriate dose adjustment in 29 - 74% of patients with 
renal impairment.2-7
Failure to adjust drug doses has several possible 
explanations. Prescribers might not review renal function 
results before prescribing. Reference texts to guide adjustment 
in renal impairment might not be freely available in the 
hospital wards. Prescribers who do not routinely check 
whether dose adjustment is required in patients with renal 
impairment might selectively adjust drugs that are well-
known to require dose adjustment, and be unaware of the 
need for dose adjustment of other drugs. Prescribers might 
have used different methods from ours to calculate and define 
renal impairment, such as only using serum creatinine as 
an indicator of renal impairment rather than calculating the 
eGFR. This omission might have resulted in significant renal 
impairment being missed in lighter patients. The hospital 
laboratory does not routinely calculate creatinine clearances 
when a creatinine test is requested, and clinicians would 
therefore have to calculate the clearance themselves before 
prescribing. When calculating eGFR, prescribers might have 
used the Cockroft-Gault formula (eGFR=[(140–age) × weight]/
Scr × 0.85 if female) rather than the MDRD formula.10 The 
Cockroft-Gault formula is unlikely to have been used to 
calculate eGFR in many of the patients in our study, because 
weight is a variable required when using the Cockroft-Gault 
formula, and weight was only documented in 60% of patients 
with renal impairment. Lastly, a critically ill patient may 
experience rapid changes in renal function, making eGFR 
extremely difficult and unreliable. The limitations of currently 
available eGFR equations have been widely acknowledged 
Table I. Patient characteristics (N=97)
Sex   50 (52%) female
Ethnicity   33 (34%) black
Median age (IQR)  46 (23 - 79) years
Median weight (IQR) 64 (54 - 73) kg*
Median creatinine (IQR) 448 (314 - 950) µmol/l
Median GFR (IQR)  19.2 (8.9 - 33.1) ml/min/1.73 m2
Median drugs   6 (1 - 15)
prescribed (range)
≥5 drugs per script   53/97 (55%)
*Weight available for only  58/97 (60%) patients.
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in patients with acute renal impairment.12,13 Prescribers 
might have opted not to dose adjust in patients with acute 
deterioration in renal function, with the expectation that renal 
function would improve and out of concern for under-dosing.
Our study has limitations. It was conducted retrospectively 
so as not to influence prescribing habits. Retrospective data 
collection may be hampered by missing and incomplete data, 
and we could not locate folders in 30% of medical admissions, 
which decreased our sample size. However, the patients with 
missing folders are unlikely to have differed in any systematic 
way from patients whose folders were located. It is therefore 
unlikely that inability to locate their folders introduced bias. 
As the study was retrospective, we could not determine what 
method, if any, prescribers used to identify renal impairment 
and assess the severity of renal impairment in patients in 
our study. We used the internationally recommended MDRD 
formula, which includes an adjustment factor in the equation 
for African-Americans to estimate GFR.10 The South African 
Renal Society recommends use of this adjustment factor in 
black African patients, and omission of the adjustment factor 
in patients of all other ethnic backgrounds.11 As this was a 
retrospective chart review, we could not acquire self-defined 
ethnicity data, or data on ethnic ancestry, from patients. We 
therefore identified black African patients as those who were 
recorded as Xhosa-speaking on their admission records, which 
might have resulted in misclassification of some patients. 
To our knowledge, there are no data on performance of 
the MDRD formula in a southern African population, and 
there may be differences between our population and the 
population in which the formula was originally developed and 
validated. Dose adjustment in rapidly changing renal function 
is controversial, and some of the failure to dose adjust might 
have been due to prescribers electing not to adjust dosing 
during acute renal impairment. Our study design did not allow 
us to differentiate between acute and chronic renal impairment. 
Lastly, prescribers might have used a different reference source 
from that which we used.
Studies have suggested methods to improve adherence 
to dose adjustment recommendations in renal impairment. 
Computer-guided drug dosing for inpatients with renal 
impairment has been shown to result in an increase in correct 
dosing of renally eliminated drugs.20 Automated eGFR 
reporting in renal function reports are already standard 
practice in many South African private laboratories and may 
alert the prescribing clinician to the presence of significant 
renal impairment.
We found that clinicians frequently neglected to adjust doses 
in renally impaired patients. Renal impairment is common in 
medical inpatients, and it is therefore important to increase 
awareness of the importance of dose adjustment and improve 
adherence to dose adjustment recommendations. Increasing 
availability of reference texts in medical wards, providing 
clinicians with an eGFR with all creatinine results, and 
electronic aids to identify drugs requiring dose adjustment, 
should be considered.
We thank Professor Charles Swanepoel for his input.
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